Logo image of RDC.DE

REDCARE PHARMACY NV (RDC.DE) Stock Fundamental Analysis

FRA:RDC - Deutsche Boerse Ag - NL0012044747 - Common Stock - Currency: EUR

114.5  -0.3 (-0.26%)

Fundamental Rating

4

Taking everything into account, RDC scores 4 out of 10 in our fundamental rating. RDC was compared to 26 industry peers in the Consumer Staples Distribution & Retail industry. RDC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. RDC is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RDC had negative earnings in the past year.
In the past year RDC had a positive cash flow from operations.
In the past 5 years RDC always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: RDC reported negative operating cash flow in multiple years.
RDC.DE Yearly Net Income VS EBIT VS OCF VS FCFRDC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.41%, RDC is doing worse than 76.92% of the companies in the same industry.
Looking at the Return On Equity, with a value of -4.86%, RDC is doing worse than 73.08% of the companies in the same industry.
Industry RankSector Rank
ROA -2.41%
ROE -4.86%
ROIC N/A
ROA(3y)-7.1%
ROA(5y)-6.58%
ROE(3y)-14.02%
ROE(5y)-12.32%
ROIC(3y)N/A
ROIC(5y)N/A
RDC.DE Yearly ROA, ROE, ROICRDC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -100 -200 -300 -400

1.3 Margins

RDC has a Gross Margin of 23.20%. This is comparable to the rest of the industry: RDC outperforms 53.85% of its industry peers.
In the last couple of years the Gross Margin of RDC has grown nicely.
RDC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.59%
GM growth 5Y5.88%
RDC.DE Yearly Profit, Operating, Gross MarginsRDC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

More info and screens

6

2. Health

2.1 Basic Checks

RDC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RDC has been increased compared to 1 year ago.
The number of shares outstanding for RDC has been increased compared to 5 years ago.
RDC has a better debt/assets ratio than last year.
RDC.DE Yearly Shares OutstandingRDC.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
RDC.DE Yearly Total Debt VS Total AssetsRDC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 4.86 indicates that RDC is not in any danger for bankruptcy at the moment.
RDC has a better Altman-Z score (4.86) than 80.77% of its industry peers.
A Debt/Equity ratio of 0.46 indicates that RDC is not too dependend on debt financing.
The Debt to Equity ratio of RDC (0.46) is better than 80.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z 4.86
ROIC/WACCN/A
WACC6.65%
RDC.DE Yearly LT Debt VS Equity VS FCFRDC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

2.3 Liquidity

A Current Ratio of 2.12 indicates that RDC has no problem at all paying its short term obligations.
The Current ratio of RDC (2.12) is better than 92.31% of its industry peers.
RDC has a Quick Ratio of 1.53. This is a normal value and indicates that RDC is financially healthy and should not expect problems in meeting its short term obligations.
RDC's Quick ratio of 1.53 is amongst the best of the industry. RDC outperforms 96.15% of its industry peers.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.53
RDC.DE Yearly Current Assets VS Current LiabilitesRDC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

RDC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.70%.
RDC shows a strong growth in Revenue. In the last year, the Revenue has grown by 39.58%.
RDC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.22% yearly.
EPS 1Y (TTM)-29.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-195.62%
Revenue 1Y (TTM)39.58%
Revenue growth 3Y22.94%
Revenue growth 5Y27.22%
Sales Q2Q%20.83%

3.2 Future

The Earnings Per Share is expected to grow by 62.88% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 21.02% on average over the next years. This is a very strong growth
EPS Next Y-91.9%
EPS Next 2Y5.01%
EPS Next 3Y54.58%
EPS Next 5Y62.88%
Revenue Next Year33.02%
Revenue Next 2Y28.68%
Revenue Next 3Y25.84%
Revenue Next 5Y21.02%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
RDC.DE Yearly Revenue VS EstimatesRDC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
RDC.DE Yearly EPS VS EstimatesRDC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 6 8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RDC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RDC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RDC.DE Price Earnings VS Forward Price EarningsRDC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

RDC's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. RDC is more expensive than 76.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 45.44
RDC.DE Per share dataRDC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

A more expensive valuation may be justified as RDC's earnings are expected to grow with 54.58% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.01%
EPS Next 3Y54.58%

More info and screens

0

5. Dividend

5.1 Amount

RDC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REDCARE PHARMACY NV

FRA:RDC (2/21/2025, 7:00:00 PM)

114.5

-0.3 (-0.26%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)11-05 2024-11-05/bmo
Earnings (Next)03-11 2025-03-11/amc
Inst Owners38.3%
Inst Owner ChangeN/A
Ins Owners10.37%
Ins Owner ChangeN/A
Market Cap2.36B
Analysts76.84
Price Target162.03 (41.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-56.32%
Min EPS beat(2)-159.9%
Max EPS beat(2)47.26%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)23.06%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)47.4%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.59%
PT rev (3m)3.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-389.84%
EPS NY rev (1m)-56.3%
EPS NY rev (3m)-56.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.06
P/FCF N/A
P/OCF 76.01
P/B 4.66
P/tB 25.86
EV/EBITDA 45.44
EPS(TTM)-1.29
EYN/A
EPS(NY)-0.9
Fwd EYN/A
FCF(TTM)-0.51
FCFYN/A
OCF(TTM)1.51
OCFY1.32%
SpS108.2
BVpS24.55
TBVpS4.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.41%
ROE -4.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.2%
FCFM N/A
ROA(3y)-7.1%
ROA(5y)-6.58%
ROE(3y)-14.02%
ROE(5y)-12.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.59%
GM growth 5Y5.88%
F-Score3
Asset Turnover2.19
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Debt/EBITDA 4.68
Cap/Depr 60.13%
Cap/Sales 1.87%
Interest Coverage N/A
Cash Conversion 61.8%
Profit Quality N/A
Current Ratio 2.12
Quick Ratio 1.53
Altman-Z 4.86
F-Score3
WACC6.65%
ROIC/WACCN/A
Cap/Depr(3y)120.76%
Cap/Depr(5y)158.72%
Cap/Sales(3y)3.55%
Cap/Sales(5y)3.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-195.62%
EPS Next Y-91.9%
EPS Next 2Y5.01%
EPS Next 3Y54.58%
EPS Next 5Y62.88%
Revenue 1Y (TTM)39.58%
Revenue growth 3Y22.94%
Revenue growth 5Y27.22%
Sales Q2Q%20.83%
Revenue Next Year33.02%
Revenue Next 2Y28.68%
Revenue Next 3Y25.84%
Revenue Next 5Y21.02%
EBIT growth 1Y-48.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year447.34%
EBIT Next 3Y139.94%
EBIT Next 5Y97.59%
FCF growth 1Y84.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y288.93%
OCF growth 3Y51.14%
OCF growth 5YN/A